Dyadic and Cygnus Technologies Announce Partnership To Provide C1 HCP ELISA Assay to Enhance Quality Assurance in Biomanufacturing
February 13, 2024 08:30 ET
|
Dyadic International, Inc.
JUPITER, Fla. and LELAND, N.C., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Dyadic International Inc. (“Dyadic”, or the “Company”) (Nasdaq: DYAI) and Cygnus Technologies®, part of Maravai LifeSciences®...
Biologics Contract Development & Manufacturing Organization Market revenue to hit USD 39 Billion by 2036, says Research Nester
February 08, 2024 05:30 ET
|
Research Nester
New York, Feb. 08, 2024 (GLOBE NEWSWIRE) -- The global biologics contract development & manufacturing organization (CDMO) market size is projected to grow at a CAGR of over ~12% from 2024 to...
Recombinant Proteins Market revenue to hit USD 9 Billion by 2035, says Research Nester
January 25, 2024 05:30 ET
|
Research Nester
New York, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The global recombinant proteins market size is slated to expand at ~12.80% CAGR between 2023 and 2035. The market is poised to garner a revenue of USD 9...
Biopharmaceuticals Contract Manufacturing Market Research 2023-2030 'Reports Insights'
February 27, 2023 07:00 ET
|
REPORTSINSIGHTS CONSULTING PVT LTD
New York, Feb. 27, 2023 (GLOBE NEWSWIRE) -- The Biopharmaceuticals Contract Manufacturing Market is projected to grow at a CAGR of 5.6% from 2023 to 2030, reaching a value of USD 27.6 Billion by...
AGC Biologics Honored for Innovations in Cell Line Development
October 13, 2022 08:37 ET
|
AGC Biologics
Seattle, Oct. 13, 2022 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced it has been named a 2022...
AGC Biologics Named Manufacturing Company of the year by American Business Awards
June 29, 2022 09:09 ET
|
AGC Biologics
SEATTLE, June 29, 2022 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced it was named Company of the...
AGC Biologics Honored as a Top 10 Company for Pharma Quality Assurance
June 09, 2022 08:22 ET
|
AGC Biologics
SEATTLE, June 09, 2022 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced it has been named a Top 10...
$27.86Bn by 2028, Biopharmaceutical Contract Manufacturing Market Size, 8.5% CAGR Lead by Biologics - Exclusive Research Report by The Insight Partners
February 17, 2022 05:57 ET
|
The Insight Partners
New York, Feb. 17, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Biopharmaceutical Contract Manufacturing Market Forecast to 2028 - COVID-19 Impact and Global...
Protein Expression Market Size to Reach USD 6.07 Billion in 2028; CAGR of 13.5% | Reports And Data
April 19, 2021 13:00 ET
|
Reports and Data
New York, April 19, 2021 (GLOBE NEWSWIRE) -- Rising demand for vaccines and protein therapeutics, increasing R&D initiatives in biopharmaceutical sector, and rising prevalence of acute and...
Cell Line Development Market will retain 13% CAGR to touch USD 7.5 bn by 2024: Global Market Insights, Inc.
September 20, 2018 05:00 ET
|
Global Market Insights, Inc
Sellbyville, Delaware, Sept. 20, 2018 (GLOBE NEWSWIRE) -- Global Cell Line Development Market will surpass USD 7.5 billion by 2024; according to a new research report by Global Market Insights,...